Company Filing History:
Years Active: 2024
Title: Guibo Sun: Innovator in Cardiovascular and Cerebrovascular Drug Development
Introduction
Guibo Sun is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly in the development of drugs aimed at preventing and treating cardiovascular and cerebrovascular diseases. His innovative approach combines traditional herbal medicine with modern pharmacology.
Latest Patents
Guibo Sun holds a patent for the use of a combination or composition of Radix et Rhizoma Notoginseng and aspirin. This patent details an application of this combination in the preparation of a drug designed to prevent and treat cardiovascular and cerebrovascular diseases. The specified dose range for Radix et Rhizoma Notoginseng is 25-500 mg/d, while the dose range for aspirin is 20-700 mg/d. The combination not only demonstrates a synergistic effect but also aims to reduce gastric mucosal damage typically caused by aspirin. He has 1 patent to his name.
Career Highlights
Guibo Sun is affiliated with the Chinese Academy of Medical Sciences, where he conducts research and development in the field of medical sciences. His work focuses on integrating traditional medicine with contemporary therapeutic practices, showcasing his commitment to advancing healthcare solutions.
Collaborations
Guibo Sun collaborates with notable colleagues, including Xiaobo Sun and Xiangbao Meng. Their combined expertise contributes to the innovative research and development efforts at the Chinese Academy of Medical Sciences.
Conclusion
Guibo Sun's contributions to the field of medicine through his innovative patent highlight the potential of combining traditional and modern approaches to drug development. His work continues to pave the way for advancements in treating cardiovascular and cerebrovascular diseases.